2025年2月28日,浙江太美医疗科技股份有限公司(以下简称“太美医疗科技”,股份代号:02576.HK)连同其附属公司统称“集团”发布盈利预告,对截至2024年12月31日止年度(“2024财年”)的未经审计综合管理账目以及管理层目前可得的其他资料进行了初步审阅,结果显示预计2024财年亏损净额将不超过人民币2.2亿元,相较于2023财年的3.56亿元亏损净额减少不少于38%。此外,根据该集团...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.